| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
1.00 µM |
U937 |
Homo sapiens |
|
|
|
| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
2.00 µM |
U937 |
Homo sapiens |
|
|
|
| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
3.00 µM |
U937 |
Homo sapiens |
|
|
|
| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
4.00 µM |
U937 |
Homo sapiens |
|
|
|
| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
1.00 µM |
KG-1 |
Homo sapiens |
|
|
|
| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
2.00 µM |
KG-1 |
Homo sapiens |
|
|
|
| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
3.00 µM |
KG-1 |
Homo sapiens |
|
|
|
| Arsenic trioxide |
Influence on cell viability in presence of ruxolitinib |
MTT Assay |
4.00 µM |
KG-1 |
Homo sapiens |
|
|
|
